Russia and China to build a new pharmaceutical plant in the Irkutsk region
A Russian pharmaceutical company and its Chinese partner have announced the launch of a joint project to build a new production facility. The enterprise will specialize in creating pharmaceutical substances necessary for the manufacturing of medicinal products.
The total investment in this project is estimated at 13.06 billion tenge. The plant will be located in the Irkutsk region. The choice of region is due to its developed infrastructure and convenient geographical location for the subsequent distribution of finished products.
Cooperation with Chinese partners will allow for the use of modern technologies and equipment. It is expected that the launch of the new production facility will help strengthen the country's pharmaceutical independence and expand the range of available medicines on the domestic market.
The construction of the plant is an important step in the development of bilateral economic relations between Russia and China. The implementation of the project is scheduled to be completed in the coming years, after which the enterprise will begin full-scale operations and provide new jobs for residents of the region.